# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Canaccord Genuity analyst Maria Ripps maintains Hims & Hers Health (NYSE:HIMS) with a Buy and raises the price target fr...
Citigroup analyst Daniel Grosslight downgrades Hims & Hers Health (NYSE:HIMS) from Buy to Neutral and raises the price t...
Roundhill CEO Dave Mazza says investors "can't just buy a basket of big pharma names or a broad-based biotech ETF and c...
Retail traders could be shifting away from meme stocks to several other stocks seeing strong interest on WallSteetBets.
NVDAAIHIMSTSLADJTGMEPANWTNDMBBQQQData from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment
Wall Street rallies on Monday as major US indices reach fresh record highs. Metal commodities surge, Treasury yields stay stabl...